NCT07493161
- Conditions
- Ph+ ALL
- Locations
-
- Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Ph+ ALL
Explore clinical trials studying Ph+ ALL. Study availability and eligibility vary by location and protocol.
4 public trials
2 recruiting studies
Ph+ ALL trial results
NCT06051409
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Ascentage Investigative Site #1044 Birmingham, Alabama, United States
- Ascentage Investigative Site #1062 Duarte, California, United States
- Ascentage Investigative Site #1134 Los Angeles, California, United States
- Ascentage Investigative Site #1059 Los Angeles, California, United States
Not Yet Recruiting
Efficacy and Safety of Olverembatinib Plus Inotuzumab Ozogamicin as First-Line Consolidation Therapy Followed by HSCT in Ph+ ALL
NCT07443488
- Conditions
- HSCT, Ph+ ALL
- Locations
-
Not specified
NCT03678454
- Conditions
- Bone Marrow Diseases, CML, Chronic Disease, +14 more
- Locations
-
- ZNA Stuyvenberg Antwerp, Belgium
- UZ Antwerpen Antwerp, Belgium
- AZ Klina Brasschaat, Belgium
- AZ St-Jan Brugge Bruges, Belgium